GW Pharmaceuticals - 6 Year Stock Price History | GWPH

Historical daily share price chart and data for GW Pharmaceuticals since 2013 adjusted for splits. The latest closing stock price for GW Pharmaceuticals as of May 24, 2019 is 183.62.
  • The all-time high GW Pharmaceuticals stock price is 187.21, which is 2% above the current share price.
  • The GW Pharmaceuticals 52-week high stock price is 187.21, which is 2% above the current share price.
  • The GW Pharmaceuticals 52-week low stock price is 94.36, which is 48.6% below the current share price.
  • The average GW Pharmaceuticals stock price for the last 52 weeks is 147.16.
GW Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 157.7667 101.0100 187.2100 99.6900 183.6200 88.54%
2018 135.9010 134.0900 174.5000 94.3600 97.3900 -26.23%
2017 113.6863 112.3800 138.7600 94.1400 132.0100 18.13%
2016 89.0206 68.4600 134.0200 36.6400 111.7500 60.93%
2015 96.9463 70.0400 129.6900 64.9600 69.4400 2.60%
2014 72.8060 40.5800 107.3500 38.0600 67.6800 62.93%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.538B $0.013B
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $135.807B 26.36
Medtronic (MDT) Ireland $124.767B 17.82
Stryker (SYK) United States $68.939B 24.60
Boston Scientific (BSX) United States $53.498B 25.65
Baxter (BAX) United States $38.314B 24.15
Zimmer Biomet Holdings (ZBH) United States $23.453B 15.07
Smith & Nephew SNATS (SNN) United Kingdom $18.518B 0.00
ResMed (RMD) United States $16.331B 31.20
Canopy Growth (CGC) Canada $15.286B 0.00
Bio-Rad Laboratories (BIO) United States $8.742B 46.35
Aurora Cannabis (ACB) Canada $8.427B 83.10
Hill-Rom Holdings (HRC) United States $6.498B 19.70
Insulet (PODD) United States $6.479B 472.04
Perrigo (PRGO) Ireland $6.439B 10.89
Haemonetics (HAE) United States $5.172B 42.26
ICU Medical (ICUI) United States $4.652B 27.76
Hutchison China MediTech (HCM) China $3.574B 0.00
NuVasive (NUVA) United States $3.193B 26.07
Neogen (NEOG) United States $2.974B 48.36
Agios Pharmaceuticals (AGIO) United States $2.838B 0.00
National Vision Holdings (EYE) United States $2.257B 48.10
Quidel (QDEL) United States $2.184B 22.66
Aphria (APHA) $1.843B 0.00
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.376B 790.40
Phibro Animal Health (PAHC) United States $1.203B 18.02
AtriCure (ATRC) United States $1.140B 0.00
VAREX IMAGING (VREX) United States $1.042B 22.11
NanoString Technologies (NSTG) United States $0.973B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.49
MacroGenics (MGNX) United States $0.920B 0.00
Omeros (OMER) United States $0.876B 0.00
PetIQ (PETQ) United States $0.779B 18.92
Eagle Pharmaceuticals (EGRX) United States $0.756B 21.21
Cerus (CERS) United States $0.715B 0.00
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.572B 83.22
LeMaitre Vascular (LMAT) United States $0.524B 25.35
OraSure Technologies (OSUR) United States $0.509B 23.46
Quanterix (QTRX) United States $0.505B 0.00
Meridian Bioscience (VIVO) United States $0.477B 14.57
Evolus (EOLS) United States $0.440B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.336B 0.00
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.302B 20.93
Vapotherm (VAPO) United States $0.284B 0.00
Rockwell Medical (RMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.230B 23.80
Owens & Minor (OMI) United States $0.219B 4.64
Cytosorbents (CTSO) United States $0.213B 0.00
Bovie Medical (APYX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Fonar (FONR) United States $0.130B 6.83
Chembio Diagnostics (CEMI) United States $0.120B 0.00
BRAINSWAY LTD (BWAY) Israel $0.118B 0.00
Female Health (VERU) United States $0.112B 0.00
Surface Oncology (SURF) United States $0.107B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
United-Guardian (UG) United States $0.091B 20.10
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.33
Oramed Pharmaceuticals (ORMP) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
Myomo (MYO) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 4.57